Ms. Sommy Rhee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24 Larchwood, Irvine, CA 92602 Phone: 714-585-0322 |
Tiffany Nguyen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9401 Jeronimo Rd, Irvine, CA 92618 Phone: 714-516-5427 |
Ali Khosrovani Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 12201 Pintado, Irvine, CA 92618 Phone: 310-606-0146 |
Dr. Saeed Binaei, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 645 Turtle Crest Dr, Irvine, CA 92603 Phone: 949-374-6679 Fax: 949-861-9439 |
Dr. Keri Kathleen Hurley-kim, PHARMD, MPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 802 W Peltason Dr, Irvine, CA 92697 Phone: 760-914-1011 |
Danvy Hoang Nguyen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16 Trovita, Irvine, CA 92620 Phone: 714-728-5197 |
Bao Vuong, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 11 Festivo, Irvine, CA 92606 Phone: 714-230-5336 |
Martin Tuan Tran, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4042 Belvedere, Irvine, CA 92604 Phone: 949-307-2075 |
Jeanne Won, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 Technology Dr, Irvine, CA 92618 Phone: 949-453-9733 |
Ngoc Hong Tran, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14330 Culver Dr, Irvine, CA 92604 Phone: 949-559-8129 Fax: 949-559-9103 |
Afshan Mobin Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Redwood Tree Ln, Irvine, CA 92612 Phone: 714-516-8212 |
Mr. Dae Kim, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4541 Campus Dr, Irvine, CA 92612 Phone: 949-854-8280 Fax: 949-854-7319 |
Dr. Anika Tasnia Haque, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3981 Irvine Blvd, Irvine, CA 92602 Phone: 714-368-0991 |
Dr. Brian I Kawahara, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9401 Jeronimo Rd, Irvine, CA 92618 Phone: 714-516-5407 |
Dr. Cheryl Rim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Willard, Irvine, CA 92604 Phone: 949-262-5758 Fax: 949-262-5701 |
Steve Suk-hee Lee, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16300 Sand Canyon Ave, Ste 101, Irvine, CA 92618 Phone: 949-453-9789 Fax: 949-453-9235 |
Jennifer Hyun Kim Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14433 Culver Dr, Irvine, CA 92604 Phone: 949-422-1010 |
Lauren Caffery Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3981 Irvine Blvd, Irvine, CA 92602 Phone: 714-368-0991 |
Dr. James Jacob Boley, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2223 Scholarship, Irvine, CA 92612 Phone: 661-754-0908 Fax: 708-713-8129 |
Ginny Ma, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4541 Campus Dr, Irvine, CA 92612 Phone: 949-854-8280 |
News Archive
The coronavirus strain called 2019-nCoV has been causing widespread illness in China, with 28,276 affected by the virus and over 565 deaths worldwide, mostly in China. As of now, it is already more deadly than the SARS epidemic that raged between 2002 and 2004.
Circadian rhythms may play a crucial role in the recovery of consciousness of patients with severe brain injuries, a study published in Neurology.
Vertex Pharmaceuticals Incorporated today announced positive results from a 24-week analysis of the ongoing Phase 3 ENVISION study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month.
› Verified 9 days ago